FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:1396-1397 September 28, 2006 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

To the Editor: Vivas et al. (June 8 issue)¹ describe a patient with refractory celiac disease who had a response to treatment with alemtuzumab. It is not clear whether the percentage of aberrant intraepithelial lymphocytes decreased while the patient was receiving alemtuzumab, since only T cells are mentioned. However, the aberrant T-cell population (CD7+CD3–CD4–CD8– cytoplasmic CD3+) determines the risk of enteropathy-associated T-cell lymphoma. This population is distinct from the population of T cells.^2,3

We report on a 66-year-old woman who had refractory celiac disease with progressively more aberrant intraepithelial lymphocytes despite treatment with alemtuzumab. The patient had been on a . . . [Full Text of this Article]

Related Letters:

Alemtuzumab for Refractory Celiac Disease in a Patient at Risk for Enteropathy-Associated T-Cell Lymphoma
Vivas S., de Morales J. M. R., Ramos F., Suárez-Vilela D.
Extract | Full Text | PDF  
N Engl J Med 2006; 354:2514-2515, Jun 8, 2006. Correspondence

This article has been cited by other articles:

• Al-toma, A., Visser, O. J., van Roessel, H. M., von Blomberg, B. M. E., Verbeek, W. H. M., Scholten, P. E. T., Ossenkoppele, G. J., Huijgens, P. C., Mulder, C. J. J. (2007). Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood 109: 2243-2249 [Abstract] [Full Text]